Sigma Healthcare shares take off

Scott Olson/Getty Images

Shares in Sigma Healthcare jumped after the pharmacy supplier announced a negotiated settlement with Chemist Warehouse over a wholesale supply agreement dispute.

A short time ago, the shares were up 3.8% to $0.862.

As a result of this settlement, Sigma confirmed current year EBIT (earnings before interest and taxes) guidance of $90 million with 2019 expected to be at a similar level.

“Importantly, both parties are committed to a more constructive approach to discussions for a new agreement, with discussions expected to advance over the 2018 calendar year,” says Sigma CEO Mark Hooper.

Legal proceedings started in May after the privately-owned My Chemist/Chemist Warehouse Group, said to have national sales of about $2.7 billion, indicated it was going to source products from another wholesaler.

Sigma, which owns the Amcal and Guardian brands, maintained that My Chemist/Chemist Warehouse Group, under an agreement running to June 2019, is not entitled to acquire products from another wholesaler.

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.